Back to Results
First PageMeta Content
Science / Genomics / Biomarker discovery / Proteomics / Biomarker / Critical Path Institute / Personalized medicine / Pharmaceutical industry / Targeted therapy / Biology / Medicine / Pharmacology


Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine Martin LeBlanc, President and CEO, Caprion The 2014 ISPIM Americas Innovation Forum
Add to Reading List

Document Date: 2014-10-31 10:29:23


Open Document

File Size: 1,33 MB

Share Result on Facebook

City

Montreal / /

Company

Personalized Medicine Partnership / Public-Private Partnerships / Great Point Partners LLC / Wellcome Trust / Caprion Pharma / Vitro Diagnostics / Chicago Growth Partners / /

Country

Canada / /

Currency

USD / /

Facility

FDA Critical Path Institute / /

IndustryTerm

pharmaceutical industry / healthcare providers / diagnostic products / immune monitoring services / /

MedicalCondition

cancer / disease / Infectious disease / Diabetes / /

Organization

FDA / Out-license hospital / European Personalized Medicine Association / FDA Critical Path Institute / /

Position

Prime Minister / President and CEO / /

ProvinceOrState

Quebec / California / /

Technology

proteomics / Drug Discovery / Drug Development / /

SocialTag